1、Singh RB, Saini C, Shergill S, et al. Window to the circulatory system:
ocular manifestations of cardiovascular diseases[ J]. Eur J Ophthalmol,
2020, 30(6): 1207-1219.Singh RB, Saini C, Shergill S, et al. Window to the circulatory system:
ocular manifestations of cardiovascular diseases[ J]. Eur J Ophthalmol,
2020, 30(6): 1207-1219.
2、Aschauer J, Aschauer S, Pollreisz A, et al. Identi cation of subclinical
microvascular biomarkers in coronary heart disease in retinal
imaging[ J]. Trans Vis Sci Tech, 2021, 10(13): 24.Aschauer J, Aschauer S, Pollreisz A, et al. Identi cation of subclinical
microvascular biomarkers in coronary heart disease in retinal
imaging[ J]. Trans Vis Sci Tech, 2021, 10(13): 24.
3、Mokri B, Silbert PL, Schievink WI, et al. Cranial nerve palsy in
spontaneous dissection of the extracranial internal carotid artery[ J].
Neurology, 1996, 46(2): 356-359.Mokri B, Silbert PL, Schievink WI, et al. Cranial nerve palsy in
spontaneous dissection of the extracranial internal carotid artery[ J].
Neurology, 1996, 46(2): 356-359.
4、Cordina R, Leaney J, Golzan M, et al. Ophthalmological consequences
of cyanotic congenital heart disease: vascular parameters and nerve
bre layer[ J]. Clin Exp Ophthalmol, 2015, 43(2): 115-123.Cordina R, Leaney J, Golzan M, et al. Ophthalmological consequences
of cyanotic congenital heart disease: vascular parameters and nerve
bre layer[ J]. Clin Exp Ophthalmol, 2015, 43(2): 115-123.
5、Mansour AM, Bitar FF, Traboulsi EI, et al. Ocular pathology in
congenital heart disease[ J]. Eye, 2005, 19(1): 29-34.Mansour AM, Bitar FF, Traboulsi EI, et al. Ocular pathology in
congenital heart disease[ J]. Eye, 2005, 19(1): 29-34.
6、Li C, Zhong P, Yuan H, et al. Retinal microvasculature impairment in
patients with congenital heart disease investigated by optical coherence
tomography angiography[ J]. Clin Exp Ophthalmol, 2020, 48(9): 1219-
1228.Li C, Zhong P, Yuan H, et al. Retinal microvasculature impairment in
patients with congenital heart disease investigated by optical coherence
tomography angiography[ J]. Clin Exp Ophthalmol, 2020, 48(9): 1219-
1228.
7、Hasbun R, Vikram HR, Barakat LA, et al. Complicated le -sided native
valve endocarditis in adults[ J]. JAMA, 2003, 289(15): 1933.Hasbun R, Vikram HR, Barakat LA, et al. Complicated le -sided native
valve endocarditis in adults[ J]. JAMA, 2003, 289(15): 1933.
8、Panja M, Mondal PC. Current status of aortoarteritis in India[ J]. J
Assoc Physicians India, 2004, 52: 48-52.Panja M, Mondal PC. Current status of aortoarteritis in India[ J]. J
Assoc Physicians India, 2004, 52: 48-52.
9、刘轩, 雷剑琴, 陈丽, 等. 首诊眼科的Takayasu动脉炎1例[J]. 中国眼耳鼻喉科杂志, 2023, 23(1): 93-95.
Liu X, Lei JQ Chen L, et al. A case of Takayasu arteritis with initial ophthalmic diagnosis [J] Chin J Ophthal & Otorhinol, 2023, 23 (1): 93-95.刘轩, 雷剑琴, 陈丽, 等. 首诊眼科的Takayasu动脉炎1例[J]. 中国眼耳鼻喉科杂志, 2023, 23(1): 93-95.
Liu X, Lei JQ Chen L, et al. A case of Takayasu arteritis with initial ophthalmic diagnosis [J] Chin J Ophthal & Otorhinol, 2023, 23 (1): 93-95.
10、De Smit E, O’Sullivan E, MacKey DA, et al. Giant cell arteritis:
ophthalmic manifestations of a systemic disease[ J]. Graefes Arch Clin
Exp Ophthalmol, 2016, 254(12): 2291-2306.De Smit E, O’Sullivan E, MacKey DA, et al. Giant cell arteritis:
ophthalmic manifestations of a systemic disease[ J]. Graefes Arch Clin
Exp Ophthalmol, 2016, 254(12): 2291-2306.
11、Schmidt D, Hetzel A, Geibel-Zehender A. Retinal arterial occlusion
due to embolism of suspected cardiac tumors: report on two patients
and review of the topic[ J]. Eur J Med Res, 2005, 10(7): 296-304.Schmidt D, Hetzel A, Geibel-Zehender A. Retinal arterial occlusion
due to embolism of suspected cardiac tumors: report on two patients
and review of the topic[ J]. Eur J Med Res, 2005, 10(7): 296-304.
12、Chen L, Gordon LK. Ocular manifestations of multiple sclerosis[ J].
Curr Opin Ophthalmol, 2005, 16(5): 315-320.Chen L, Gordon LK. Ocular manifestations of multiple sclerosis[ J].
Curr Opin Ophthalmol, 2005, 16(5): 315-320.
13、干霖洋,钟勇. 与眼科相关的中枢神经系统血管性疾病[ J].中华
眼底病杂志, 2020, 36(4): 315-318.
Gan LY, Zhong Y. Central nervous system vascular diseases related to
ophthalmology [ J]. Chin J Fundus Dis, 2020, 36 (4): 315-318.干霖洋,钟勇. 与眼科相关的中枢神经系统血管性疾病[ J].中华
眼底病杂志, 2020, 36(4): 315-318.
Gan LY, Zhong Y. Central nervous system vascular diseases related to
ophthalmology [ J]. Chin J Fundus Dis, 2020, 36 (4): 315-318.
14、Chavan J, Joseph M. Clinical prof ile and ophthalmological
manifestations of idiopathic intracranial hypertension in adults at
a tertiary care center in India: a cross-sectional study[ J]. Indian J
Ophthalmol, 2022, 70(9): 3393.Chavan J, Joseph M. Clinical prof ile and ophthalmological
manifestations of idiopathic intracranial hypertension in adults at
a tertiary care center in India: a cross-sectional study[ J]. Indian J
Ophthalmol, 2022, 70(9): 3393.
15、Lyrer PA, Brandt T, Metso TM, et al. Clinical import of Horner
syndrome in internal carotid and vertebral artery dissection[ J].
Neurology, 2014, 82(18): 1653-1659.Lyrer PA, Brandt T, Metso TM, et al. Clinical import of Horner
syndrome in internal carotid and vertebral artery dissection[ J].
Neurology, 2014, 82(18): 1653-1659.
16、Henderson AD, Miller NR. Carotid-cavernous stula: current concepts
in aetiology, investigation, and management[ J]. Eye (Lond), 2018,
32(2): 164-172.Henderson AD, Miller NR. Carotid-cavernous stula: current concepts
in aetiology, investigation, and management[ J]. Eye (Lond), 2018,
32(2): 164-172.
17、van Dongen RM, Haan J. Symptoms related to the visual system in
migraine[ J]. F1000Research, 2019, 8: F1000FacultyRev-1219.van Dongen RM, Haan J. Symptoms related to the visual system in
migraine[ J]. F1000Research, 2019, 8: F1000FacultyRev-1219.
18、Pula JH, Yuen CA. Eyes and stroke: the visual aspects of cerebrovascular
disease[ J]. Stroke Vasc Neurol, 2017, 2(4): 210-220.Pula JH, Yuen CA. Eyes and stroke: the visual aspects of cerebrovascular
disease[ J]. Stroke Vasc Neurol, 2017, 2(4): 210-220.
19、闵妍,李子孝,王拥军.脑血管疾病中眼底特征研究进展[ J].中国
神经精神疾病杂志,2022,48(04):232-236.
Min Y, Li ZX, Wang YJ. Research progress on fundus characteristics in
cerebrovascular diseases [ J]. Chin J Neuro Dis, 2022,48 (04): 232-236.闵妍,李子孝,王拥军.脑血管疾病中眼底特征研究进展[ J].中国
神经精神疾病杂志,2022,48(04):232-236.
Min Y, Li ZX, Wang YJ. Research progress on fundus characteristics in
cerebrovascular diseases [ J]. Chin J Neuro Dis, 2022,48 (04): 232-236.
20、Glover K, Mishra D, Singh TRR. Epidemiology of ocular manifestations
in autoimmune disease[ J]. Front Immunol, 2021, 12: 744396.Glover K, Mishra D, Singh TRR. Epidemiology of ocular manifestations
in autoimmune disease[ J]. Front Immunol, 2021, 12: 744396.
21、亚洲干眼协会中国分会, 海峡两岸医药卫生交流协会眼科学专
业委员会眼表与泪液病学组, 中国医师协会眼科医师分会眼
表与干眼学组. 中国干眼专家共识：免疫性疾病相关性干眼
(2021年) [ J] . 中华眼科杂志, 2021, 57(12) : 898-907.
Chinese Branch of the Asian Dry Eye Association, the Ophthalmology
Professional Committee of the Cross Strait Medical and Health
Exchange Association, the Eye Surface and Tear Disease Group, and
the Eye Surface and Dry Eye Group of the Ophthalmologists Branch
of the Chinese Medical Doctor Association Consensus of Chinese
Dry Eye Experts: Immune Disease Related Dry Eye (2021) [ J] Chin J
Ophthalmol, 2021, 57 (12): 898-907.亚洲干眼协会中国分会, 海峡两岸医药卫生交流协会眼科学专
业委员会眼表与泪液病学组, 中国医师协会眼科医师分会眼
表与干眼学组. 中国干眼专家共识：免疫性疾病相关性干眼
(2021年) [ J] . 中华眼科杂志, 2021, 57(12) : 898-907.
Chinese Branch of the Asian Dry Eye Association, the Ophthalmology
Professional Committee of the Cross Strait Medical and Health
Exchange Association, the Eye Surface and Tear Disease Group, and
the Eye Surface and Dry Eye Group of the Ophthalmologists Branch
of the Chinese Medical Doctor Association Consensus of Chinese
Dry Eye Experts: Immune Disease Related Dry Eye (2021) [ J] Chin J
Ophthalmol, 2021, 57 (12): 898-907.
22、Bustamante-Arias A, Ruiz Lozano RE, Rodriguez-Garcia A. Dry eye
disease, a prominent manifestation of systemic autoimmune disorders
[ J]. Eur J Ophthalmol. 2022;32(6):3142-3162.Bustamante-Arias A, Ruiz Lozano RE, Rodriguez-Garcia A. Dry eye
disease, a prominent manifestation of systemic autoimmune disorders
[ J]. Eur J Ophthalmol. 2022;32(6):3142-3162.
23、Artifoni M, Rothschild PR, Brézin A, et al. Ocular inflammatory
diseases associated with rheumatoid arthritis[ J]. Nat Rev Rheumatol,
2014, 10(2): 108-116.Artifoni M, Rothschild PR, Brézin A, et al. Ocular inflammatory
diseases associated with rheumatoid arthritis[ J]. Nat Rev Rheumatol,
2014, 10(2): 108-116.
24、Dammacco R. Systemic lupus erythematosus and ocular involvement:
an overview[ J].Clin Exp Med, 2018, 18(2): 135-149.Dammacco R. Systemic lupus erythematosus and ocular involvement:
an overview[ J].Clin Exp Med, 2018, 18(2): 135-149.
25、Ozyazgan Y, Ucar D, Hatemi G, et al. Ocular involvement of beh?et’s
syndrome: a comprehensive review[ J].Clin Rev Allergy Immunol,
2015, 49(3): 298-306.Ozyazgan Y, Ucar D, Hatemi G, et al. Ocular involvement of beh?et’s
syndrome: a comprehensive review[ J].Clin Rev Allergy Immunol,
2015, 49(3): 298-306.
26、Szucs G, Szekanecz Z, Aszalos Z, et al. A wide spectrum of ocular
manifestations signify patients with systemic sclerosis[ J]. Ocular
Immunol Inamm, 2021, 29(1): 81-89.Szucs G, Szekanecz Z, Aszalos Z, et al. A wide spectrum of ocular
manifestations signify patients with systemic sclerosis[ J]. Ocular
Immunol Inamm, 2021, 29(1): 81-89.
27、Chin YH, Ng CH, Lee MH, et al. Prevalence of thyroid eye disease
in Graves’ disease: a meta-analysis and systematic review[ J]. Clin
Endocrinol, 2020, 93(4): 363-374.Chin YH, Ng CH, Lee MH, et al. Prevalence of thyroid eye disease
in Graves’ disease: a meta-analysis and systematic review[ J]. Clin
Endocrinol, 2020, 93(4): 363-374.
28、中华医学会眼科学分会眼整形眼眶病学组, 中华医学会内分
泌学分会甲状腺学组. 中国甲状腺相关眼病诊断和治疗指南
(2022年) [ J] . 中华眼科杂志, 2022, 58(9) : 646-668.
Orthopaedic ophthalmology Group, Ophthalmology Branch of
Chinese Medical Association and Thyroid Group, Endocrinology
Branch of Chinese Medical Association. Chinese Guidelines for
Diagnosis and Treatment of thyroid-related Eye Diseases (2022) [ J].
Chin J Ophthal, 2022, 58(09): 646-668.中华医学会眼科学分会眼整形眼眶病学组, 中华医学会内分
泌学分会甲状腺学组. 中国甲状腺相关眼病诊断和治疗指南
(2022年) [ J] . 中华眼科杂志, 2022, 58(9) : 646-668.
Orthopaedic ophthalmology Group, Ophthalmology Branch of
Chinese Medical Association and Thyroid Group, Endocrinology
Branch of Chinese Medical Association. Chinese Guidelines for
Diagnosis and Treatment of thyroid-related Eye Diseases (2022) [ J].
Chin J Ophthal, 2022, 58(09): 646-668.
29、Devilliers MJ, Ben Hadj Salah W, Barreau E, et al. Ocular manifestations
of viral diseases [ J]. Rev Med Interne, 2021, 42(6):401-410.Devilliers MJ, Ben Hadj Salah W, Barreau E, et al. Ocular manifestations
of viral diseases [ J]. Rev Med Interne, 2021, 42(6):401-410.
30、Perzia B, Theotoka D, Li K, et al. Treatment of ocular-involving
monkeypox virus with topical triuridine and oral tecovirimat in the
2022 monkeypox virus outbreak[ J]. Am J Ophthalmol Case Rep, 2023,
29: 101779.Perzia B, Theotoka D, Li K, et al. Treatment of ocular-involving
monkeypox virus with topical triuridine and oral tecovirimat in the
2022 monkeypox virus outbreak[ J]. Am J Ophthalmol Case Rep, 2023,
29: 101779.
31、Zhang L, Zhao N, Sha J, et al. Virology and epidemiology analyses of
global adenovirus-associated conjunctivitis outbreaks, 1953–2013[ J].
Epidemiol Infect, 2016, 144(8): 1661-1672.Zhang L, Zhao N, Sha J, et al. Virology and epidemiology analyses of
global adenovirus-associated conjunctivitis outbreaks, 1953–2013[ J].
Epidemiol Infect, 2016, 144(8): 1661-1672.
32、Zhang L, Jiang H, Wang K, et al. Long-term eects of weather condition
and air pollution on acute hemorrhagic conjunctivitis in China: a
nationalwide surveillance study in China[ J]. Environ Res, 2021, 201:
111616.Zhang L, Jiang H, Wang K, et al. Long-term eects of weather condition
and air pollution on acute hemorrhagic conjunctivitis in China: a
nationalwide surveillance study in China[ J]. Environ Res, 2021, 201:
111616.
33、Ozturker ZK. Conjunctivitis as sole symptom of COVID-19: A
case report and review of literature [ J]. Eur J Ophthalmol, 2021, 31(2):NP161-NP166.Ozturker ZK. Conjunctivitis as sole symptom of COVID-19: A
case report and review of literature [ J]. Eur J Ophthalmol, 2021, 31(2):NP161-NP166.
34、Shantha JG, Yeh S, Nguyen QD. Ebola virus disease and the eye[ J].
Curr Opin Ophthalmol, 2016, 27(6): 538-544.Shantha JG, Yeh S, Nguyen QD. Ebola virus disease and the eye[ J].
Curr Opin Ophthalmol, 2016, 27(6): 538-544.
35、Yener Aü. COVID-19 and the eye: ocular manifestations, treatment
and protection measures[ J]. Ocular Immunol Inamm, 2021, 29(6):
1225-1233.Yener Aü. COVID-19 and the eye: ocular manifestations, treatment
and protection measures[ J]. Ocular Immunol Inamm, 2021, 29(6):
1225-1233.
36、Ng XL, Betzler BK, Ng S, et al. The Eye of the Storm: COVID-19
Vaccination and the Eye [ J]. Ophthalmol er, 2022, 11(1): 81-100.Ng XL, Betzler BK, Ng S, et al. The Eye of the Storm: COVID-19
Vaccination and the Eye [ J]. Ophthalmol er, 2022, 11(1): 81-100.
37、Feizi M, Isen DR, Tavakoli M. Neuro-ophthalmic manifestations of
coronavirus disease 2019 and its vaccination: a narrative review[ J]. J
Ophthalmic Vis Res, 2023, 18(1): 113-122.Feizi M, Isen DR, Tavakoli M. Neuro-ophthalmic manifestations of
coronavirus disease 2019 and its vaccination: a narrative review[ J]. J
Ophthalmic Vis Res, 2023, 18(1): 113-122.
38、Evlice O, ?eviker SA, Filik A, et al. Ocular involvement of brucellosis: a
pooled analysis study[ J]. Ocular Immunol Inamm, 2023: 1-10.Evlice O, ?eviker SA, Filik A, et al. Ocular involvement of brucellosis: a
pooled analysis study[ J]. Ocular Immunol Inamm, 2023: 1-10.
39、Khairallah M, Abroug N, Khairallah M, et al. Ocular manifestations of
emerging arthropod-borne infectious diseases[ J]. J Curr Ophthalmol,
2021, 33(3): 227.Khairallah M, Abroug N, Khairallah M, et al. Ocular manifestations of
emerging arthropod-borne infectious diseases[ J]. J Curr Ophthalmol,
2021, 33(3): 227.
40、Fraunfelder FW. Ocular adverse drug reactions[ J]. Expert Opin Drug
Saf, 2003, 2(4): 411-420.Fraunfelder FW. Ocular adverse drug reactions[ J]. Expert Opin Drug
Saf, 2003, 2(4): 411-420.
41、Alshehri M, Joury A. Ocular adverse effects of amiodarone: a systematic
review of case reports[ J]. Optom Vis Sci, 2020, 97(7): 536-542.Alshehri M, Joury A. Ocular adverse effects of amiodarone: a systematic
review of case reports[ J]. Optom Vis Sci, 2020, 97(7): 536-542.
42、Fraunfelder FW, Fraunfelder FT. Oculogyric crisis in patients taking
cetirizine[ J]. Am J Ophthalmol, 2004, 137(2): 355-357.Fraunfelder FW, Fraunfelder FT. Oculogyric crisis in patients taking
cetirizine[ J]. Am J Ophthalmol, 2004, 137(2): 355-357.
43、Fraunfelder FW, Solomon J, Druker BJ, et al. Ocular side-effects
associated with imatinib mesylate (gleevec?)[ J]. J Ocular Pharmacol
Ther, 2003, 19(4): 371-375.Fraunfelder FW, Solomon J, Druker BJ, et al. Ocular side-effects
associated with imatinib mesylate (gleevec?)[ J]. J Ocular Pharmacol
Ther, 2003, 19(4): 371-375.
44、Fraunfelder FW. Ocular side effects associated with isotretinoin[ J].
Drugs Today (Barc), 2004, 40(1):23-27.Fraunfelder FW. Ocular side effects associated with isotretinoin[ J].
Drugs Today (Barc), 2004, 40(1):23-27.
45、Chartrand NA, Lau CK, Parsons MT, et al. Ocular side effects of
bisphosphonates: a review of literature[ J]. J Ocular Pharmacol Ther,
2023, 39(1): 3-16.Chartrand NA, Lau CK, Parsons MT, et al. Ocular side effects of
bisphosphonates: a review of literature[ J]. J Ocular Pharmacol Ther,
2023, 39(1): 3-16.
46、Mechrgui M, Kanani S. The ophthalmic side effects of topiramate: a
review[ J]. Cureus, 2022, 14(8): e28513.Mechrgui M, Kanani S. The ophthalmic side effects of topiramate: a
review[ J]. Cureus, 2022, 14(8): e28513.
47、Barriada RG, Masip D. An overview of deep-learning-based methods
for cardiovascular risk assessment with retinal images[ J]. Diagnostics,
2022, 13(1): 68.Barriada RG, Masip D. An overview of deep-learning-based methods
for cardiovascular risk assessment with retinal images[ J]. Diagnostics,
2022, 13(1): 68.
48、Jiang X, Xie M, Ma L, et al. International publication trends in the
application of artificial intelligence in ophthalmology research: an
updated bibliometric analysis[ J]. Ann Transl Med, 2023, 11(5): 219.Jiang X, Xie M, Ma L, et al. International publication trends in the
application of artificial intelligence in ophthalmology research: an
updated bibliometric analysis[ J]. Ann Transl Med, 2023, 11(5): 219.
